Cargando…
Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostate Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial
BACKGROUND: Intensification of therapy may improve outcomes for patients with high-risk localized prostate cancer. OBJECTIVE: To provide long-term follow-up data from phase III RTOG 0521, which compared a combination of androgen deprivation therapy (ADT) + external beam radiation therapy (EBRT) + do...
Autores principales: | Sartor, Oliver, Karrison, Theodore G., Sandler, Howard M., Gomella, Leonard G., Amin, Mahul B., Purdy, James, Michalski, Jeff M., Garzotto, Mark G., Pervez, Nadeem, Balogh, Alexander G., Rodrigues, George B., Souhami, Luis, Neil Reaume, M., Williams, Scott G., Hannan, Raquibul, Jones, Christopher U., Horwitz, Eric M., Rodgers, Joseph P., Feng, Felix Y., Rosenthal, Seth A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662642/ https://www.ncbi.nlm.nih.gov/pubmed/37179241 http://dx.doi.org/10.1016/j.eururo.2023.04.024 |
Ejemplares similares
-
Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408
por: Nichols, R. Charles, et al.
Publicado: (2017) -
Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415
por: Khairnar, Rahul, et al.
Publicado: (2021) -
NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma
por: Batchelor, Tracy T, et al.
Publicado: (2023) -
Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825
por: Scheurer, Michael E, et al.
Publicado: (2022) -
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent
Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial
por: Feng, Felix Y., et al.
Publicado: (2021)